Compounds > 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane

2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane and Fragile-X-Syndrome

2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane has been researched along with Fragile-X-Syndrome* in 4 studies

Other Studies

4 other study(ies) available for 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane and Fragile-X-Syndrome

Article	Year
Early abnormalities in 123I-ioflupane (DaTSCAN) imaging in the fragile X-associated tremor ataxia syndrome (FXTAS): a case report. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2013, Volume: 34, Issue:8 Topics: Aged; Ataxia; Brain; Fragile X Syndrome; Humans; Magnetic Resonance Imaging; Male; Nortropanes; Tomography, Emission-Computed, Single-Photon; Tremor	2013
Fragile X-associated tremor ataxia syndrome sine tremor. Movement disorders : official journal of the Movement Disorder Society, 2011, Aug-15, Volume: 26, Issue:10 Topics: Aged; Fragile X Mental Retardation Protein; Fragile X Syndrome; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Tegmentum Mesencephali; Tomography, Emission-Computed, Single-Photon; Tremor; Trinucleotide Repeat Expansion; Tropanes	2011
Evidence for pre and postsynaptic nigrostriatal dysfunction in the fragile X tremor-ataxia syndrome. Movement disorders : official journal of the Movement Disorder Society, 2009, Jun-15, Volume: 24, Issue:8 Topics: Aged; Ataxia; Brain Mapping; Corpus Striatum; Fragile X Syndrome; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Substantia Nigra; Synapses; Tomography, Emission-Computed, Single-Photon; Tropanes	2009
Dopamine transporter imaging study in parkinsonism occurring in fragile X premutation carriers. Neurology, 2005, Dec-27, Volume: 65, Issue:12 The authors studied four patients with parkinsonism carrying the fragile X premutation using SPECT with ([23)I]FP-CIT. They found evidence of preserved presynaptic nigrostriatal function, suggesting that parkinsonism in the X fragile premutation might be related to postsynaptic dopaminergic changes or different neurotransmitter alterations. Topics: Aged; Atrophy; Biomarkers; Brain; Brain Mapping; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Fragile X Syndrome; Genetic Predisposition to Disease; Heterozygote; Humans; Male; Middle Aged; Mutation; Neural Pathways; Parkinson Disease; Substantia Nigra; Synaptic Transmission; Syndrome; Tomography, Emission-Computed, Single-Photon; Tropanes	2005